Largest biotech companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total liabilities, at PLN 331.3B, ahead of Gilead Sciences (PLN 147.2B) and Biogen (PLN 45.2B). Figures as of 20 Nov 2026, 03:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenPLN 331.3B
- Median
- PLN 2.3B
- Combined market value
- PLN 2.97T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | PLN 331.3B | PLN 959.9B | PLN 1,774.54 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | PLN 147.2B | PLN 835.3B | PLN 673.43 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | PLN 45.2B | PLN 147.7B | PLN 999.37 | 1.70% down | 49% up | ||
| 4 | ModernaMRNA · Health Care | PLN 14.9B | PLN 326.2B | PLN 806.07 | 1.29% up | 780% up | ||
| 5 | Halozyme TherapeuticsHALO · Health Care | PLN 10B | PLN 42.9B | PLN 376.24 | 2.88% down | 39% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | PLN 5.6B | PLN 64.1B | PLN 633.23 | 3.85% down | 17% up | ||
| 7 | ImmunityBioIBRX · Health Care | PLN 4B | PLN 28.3B | PLN 26.57 | 1.94% down | 232% up | ||
| 8 | RepligenRGEN · Health Care | PLN 3.4B | PLN 44B | PLN 688.64 | 1.38% down | 12% up | ||
| 9 | Revolution MedicinesRVMD · Health Care | PLN 2.9B | PLN 139.4B | PLN 644.72 | 0.24% down | 129% up | ||
| 10 | ExelixisEXEL · Health Care | PLN 2.8B | PLN 65B | PLN 266.21 | 3.60% down | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | PLN 1.9B | PLN 46.2B | PLN 293.99 | 0.07% down | 24% up | ||
| 12 | VaxcytePCVX · Health Care | PLN 1.3B | PLN 37.4B | PLN 236.00 | 0.27% down | 23% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | PLN 1.2B | PLN 18.4B | PLN 113.43 | 1.44% down | 74% up | ||
| 14 | Kodiak SciencesKOD · Health Care | PLN 785.1M | PLN 25.9B | PLN 395.90 | 0.09% up | 399% up | ||
| 15 | Twist BioscienceTWST · Health Care | PLN 683M | PLN 30.8B | PLN 451.38 | 4.07% down | 346% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | PLN 659.8M | PLN 41.2B | PLN 482.80 | 1.44% down | 87% up | ||
| 17 | Scholar Rock HoldingSRRK · Health Care | PLN 642.1M | PLN 24.9B | PLN 203.69 | 4.94% up | 26% up | ||
| 18 | Krystal BiotechKRYS · Health Care | PLN 462M | PLN 37.8B | PLN 1,277.14 | 0.15% up | 54% up | ||
| 19 | ImmunovantIMVT · Health Care | PLN 422.3M | PLN 27.2B | PLN 131.51 | 1.96% down | 46% up | ||
| 20 | CG OncologyCGON · Health Care | PLN 157.7M | PLN 29.6B | PLN 331.20 | 2.38% up | 97% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0439 PLN).
Questions and answers
Which biotech companies in the United States rank first by total liabilities?
Amgen (PLN 331.3B), Gilead Sciences (PLN 147.2B) and Biogen (PLN 45.2B) are the top three of the 20 biotech companies in the United States ranked by total liabilities as of 20 Nov 2026, 03:08 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total liabilities.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total liabilities have a combined market value of PLN 2.97T as of 20 Nov 2026, 03:08 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.